Recce Pharmaceuticals Ltd.’s (RCE) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Recce Pharmaceuticals Ltd. is a Sell.
Recce Pharmaceuticals Ltd.’s (RCE) 20-Day exponential moving average is 0.34, while Recce Pharmaceuticals Ltd.’s (RCE) share price is AU$0.37, making it a Buy.
Recce Pharmaceuticals Ltd.’s (RCE) 50-Day exponential moving average is 0.34, while Recce Pharmaceuticals Ltd.’s (RCE) share price is AU$0.37, making it a Buy.
Recce Pharmaceuticals Ltd.’s (RCE) 10-Day exponential moving average is 0.35, while Recce Pharmaceuticals Ltd.’s (RCE) share price is AU$0.37, making it a Buy.
Recce Pharmaceuticals Ltd.’s (RCE) 100-Day exponential moving average is 0.37, while Recce Pharmaceuticals Ltd.’s (RCE) share price is AU$0.37, making it a Buy.
Recce Pharmaceuticals Ltd.’s (RCE) stock price is AU$0.37 and Recce Pharmaceuticals Ltd.’s (RCE) 50-day simple moving average is 0.33, creating a Buy signal.
Recce Pharmaceuticals Ltd.’s (RCE) stock price is AU$0.37 and Recce Pharmaceuticals Ltd.’s (RCE) 100-day simple moving average is 0.35, creating a Buy signal.
Recce Pharmaceuticals Ltd.’s (RCE) stock price is AU$0.37 and Recce Pharmaceuticals Ltd.’s (RCE) 200-day simple moving average is 0.43, creating a Sell signal.